US$ 22.51
tirzepatide label template Labels What clinicians should know about
Description
Apart from being a GLP-1 receptor agonist, it's also a GIP receptor agonist

In addition to weight loss, Semaglutide GLP-1 supports improved cardiometabolic health, leading to reductions in waist circumference, blood pressure, cholesterol, insulin resistance, and HbA1c levels

A better way to compare these treatments is by matching the medication strategy to the person
Acknowledgements The author would like to thank the Deanship of Scientific Research at Shaqra University for supporting this work
